ANNUAL GENERAL MEETING IN CIBUS NORDIC REAL ESTATE AB (PUBL)

NOTICE OF ANNUAL GENERAL MEETING OF CIBUS NORDIC REAL ESTATE AB (PUBL)

Cibus Nordic Real Estate AB (publ) holds an annual general meeting on Thursday 10 April 2025, at 10:00 a.m. CEST at 7A Posthuset, Vasagatan 28, Stockholm, Sweden. Registration starts at 9:30 a.m CEST.

The board of directors has resolved, pursuant to Chapter 7, Section 4a of the Swedish Companies Act and the company's articles of association, that shareholders shall have the right to exercise their voting rights by postal voting prior to the meeting. Consequently, shareholders may choose to exercise their voting rights at the meeting by attending in person, through a proxy or by postal voting.

REQUIREMENTS FOR PARTICIPATION

Shareholders wishing to attend the meeting must:

(i) be recorded as a shareholder in the share register kept by Euroclear Sweden AB as of Wednesday 2 April 2025; and
(ii) notify the company the intention to attend no later than Friday 4 April 2025.

Notice may be submitted in writing to the company at the address Cibus Nordic Real Estate AB (publ), "Annual general meeting", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden or by phone to +46 8 402 91 33 business days between 9:00 and 16:00, on Euroclear's website, https://anmalan.vpc.se/euroclearproxy?sprak=1 or by e-mail to GeneralMeetingService@euroclear.com. On giving notice of attendance, the shareholder should state the shareholder's name (company name), personal identity number (corporate identity number), address, telephone number and number of shares. The registration procedure described above also applies to registration for any advisors. A shareholder that exercises its voting rights through a postal voting form does not have to send in a separate notice of participation, see below under postal voting.

NOMINEE REGISTERED SHARES

In order to participate in the meeting, those whose shares are registered in the name of a nominee must have their shares owner-registered with Euroclear Sweden AB as of Wednesday 2 April 2025. Re-registration may be temporary (so-called voting rights registration) and is requested from the nominee in accordance with the nominee's routines at such time in advance as the nominee determines. Voting rights registration that the shareholder has requested and has been issued by the nominee no later than Friday 4 April 2025, will be accepted in the preparation of the share register.

POSTAL VOTING

The shareholders may exercise their voting rights at the meeting by postal voting. A special form shall be used for postal voting. The form is available on the company's website, www.cibusnordic.com and on Euroclear's website, https://anmalan.vpc.se/euroclearproxy?sprak=1.The postal voting form can also be obtained from the company or by contacting Euroclear Sweden AB at the contact information above. For the items on the agenda where the board or the nomination committee have submitted proposals, it is possible to vote Yes or No, which is clearly stated in the postal voting form. A shareholder can also abstain from voting on any item. The completed postal voting form must be received by the company no later than on Friday 4 April 2025. The postal voting form is valid as a notification to the meeting. Shareholders can, through verification with BankID, cast their postal vote electronically via Euroclear Sweden AB's website https://anmalan.vpc.se/euroclearproxy?sprak=1. Such electronic votes must be submitted no later than Friday 4 April 2025.

The completed form, including any appendices, must be sent by e-mail to GeneralMeetingService@euroclear.com or alternatively by post in original to Cibus Nordic Real Estate AB (publ), "Annual general meeting", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden. If the shareholder is a legal entity, a registration certificate or an equivalent authority document, shall be enclosed to the form. The same applies if the shareholder votes in advance by proxy. The shareholder may not provide special instructions or conditions in the postal voting form. If so, the postal vote is invalid in its entirety. Further instructions and conditions are included in the postal voting form.

PROXIES AND PROXY FORMS

Anyone who does not attend the meeting in person may exercise their right at the meeting via a proxy in possession of a signed and dated form of proxy. The same applies if a shareholder exercises its voting rights by postal voting. Forms of proxy are available on the company's website, www.cibusnordic.com, and on Euroclear's website https://anmalan.vpc.se/
euroclearproxy?sprak=1. The form of proxy may also be obtained from the company or by contacting Euroclear Sweden AB at contact information above. If the proxy is issued by a legal person, a copy of their registration certificate or equivalent authority document must be attached. The proxy must have been issued within the past year unless a longer period of validity is specified on the form of proxy, subject to a maximum of five years. To facilitate entry to the meeting, forms of proxy, registration certificates and other documentary authority must be received by the company well in advance before the meeting.

PROPOSED AGENDA

1. Opening of the meeting
2. Election of chair of the meeting
3. Preparation and approval of voting list
4. Election of one or two persons to approve the minutes
5. Examination of whether the meeting has been duly convened
6. Approval of the proposed agenda
7. Presentation by the CEO
8. Presentation of the annual report and the auditor's report and the consolidated financial statement and the auditor's report on the consolidated statements
9. Resolution on:
   1. adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet;
   2. disposition of the company's results in accordance with the adopted balance sheet and determination of record dates; and
   3. discharge from liability for the board members and the CEO
10. Determination of fees for the board of directors and auditor
11. Election of:
    1. board of directors; and
    2. auditor
12. Resolution on instruction for the nomination committee
13. Resolution on approval of remuneration report
14. Resolution on guidelines for remuneration to the executive management
15. Resolution on amendment of the articles of association
16. Resolution on authorization for the board of directors to resolve upon new issue of shares, warrants and/or convertibles
17. Resolution on authorization for the board of directors to resolve upon acquisition and transfer of own shares
18. Resolution on warrant plan, issue of warrants of series 2025/2028 and transfer of warrants of series 2025/2028
19. Resolution on Belgian warrant plan and issue of warrants of series 2025/2029
20. Closure of the meeting

PROPOSED RESOLUTIONS

Item 2 - Election of chair of the meeting

The nomination committee proposes Victoria Skoglund, Lindahl Law firm, member of the Swedish Bar Association, or if she is prevented from attending, the person the nomination committee proposes in her place, be elected chair of the meeting.

Item 9.b - Resolution on allocation of the company's results in accordance with the adopted balance sheet, determination of record dates

The board of directors proposes that the meeting resolves that a dividend of EUR 0.90 per share shall be paid from the unappropriated earnings of EUR 537,786,734, corresponding to a total dividend payment of EUR 68,657,440.5. The payment of the dividend is proposed to be made on a monthly basis, with twelve instalments, throughout the year. The first instalment is proposed to be EUR 0.07 per share, the second EUR 0.07 per share, the third EUR 0.08 per share, the fourth EUR 0.07 per share, the fifth EUR 0.07 per share, the sixth EUR 0.08 per share, the seventh EUR 0.07 per share, the eighth EUR 0.08 per share, the ninth EUR 0.08 per share, the tenth EUR 0.07 per share, the eleventh EUR 0.08 per share and EUR 0.08 per share at the twelfth instalment. The record dates for the dividend payments are proposed to be 17 April 2025, 26 May 2025, 1 July 2025, 28 July 2025, 27 August 2025, 1 October 2025, 27 October 2025, 26 November 2025, 2 January 2026, 27 January 2026, 24 February 2026 and 1 April 2026. The expected date of payment will therefore be 28 April 2025, 3 June 2025, 8 July 2025, 4 August 2025, 3 September 2025, 8 October 2025, 3 November 2025, 3 December 2025, 12 January 2026, 3 February 2026, 3 March 2026 and 10 April 2026.

The first payment of dividends on the shares that may be issued on the basis of the authorization for issuance of shares, according to item 16 below, will take place after the first record date after the issue of new shares has been registered with the Swedish Companies Registration Office and been recorded in the share register maintained by Euroclear Sweden AB. As a result, the total dividend to be proposed (assuming that the proposed authorization is fully utilized, and the shares are entered in the share register before the record date for the dividend on the first date of payment proposed above) may amount to a maximum of, in total, EUR 96,120,416.70.

The board of directors proposes that the remaining earnings is carried forward.

Item 10 - Determination of fees for the board of directors and auditors

The nomination committee proposes that the fees to the directors shall be in total EUR 231,000 (EUR 189,000), distributed with EUR 66,000 (EUR 63,000) to the chair of the board and EUR 33,000 (EUR 31,500) per board member. No remuneration shall be paid for committee work.

Fees will be paid to the auditor in accordance with approved invoices.

Item 11.a - Election of board of directors

The nomination committee proposes that the board should be composed of five directors elected by the meeting, with no alternates, for the period until the end of the next annual general meeting.

The nomination committee proposes re-election of the directors Elisabeth Norman, Stefan Gattberg, Victoria Skoglund, Nils Styf and Patrick Gylling, and new election of Stina Lindh Hök. As chair of the board, the nomination committee proposes new election of Stefan Gattberg.

Stina Lindh Hök (born 1973) has a degree in civil engineering from the KTH Royal Institute of Technology in Stockholm. Stina Lindh Hök has until January 2025 been CEO for Nyfosa. Previous experiences include COO at Nyfosa, transaction manager at Hemfosa Fastigheter and head of real estate at Fabege. Besides this, she has managed transactions within Leimdörfer (Nordanö). She has also been a board member of Fabege and Söderport Property Investment.

Information about the other proposed directors is available on the company's website, www.cibusnordic.com.

Item 11.b - Election of auditor

The nomination committee proposes that the company shall have one auditor, with no alternate.

The nomination committee proposes that the registered accounting firm Öhrlings PricewaterhouseCoopers AB be re-appointed auditor, in accordance with the board of directors' proposal, for the period until the end of the next annual general meeting. Öhrlings PricewaterhouseCoopers AB has given notice that if the nomination committee's proposal for auditor is adopted at the meeting, Johan Rippe, authorized public accountant, will be the person appointed to have main responsibility for the audit.

Item 12 - Resolution on instruction for the nomination committee

The nomination committee proposes that the following instruction shall apply to the nomination committee until a new instruction is resolved on:

The company's nomination committee shall consist of the chair of the board and three additional members appointed by the three largest shareholders in terms of voting rights.

The three largest shareholders based on Euroclear Sweden AB's list of registered shareholders as of the last banking day in August shall be contacted by the chair of the board. Following the contact, the owners shall within 7 days inform the chair if they wish to participate in the work of the nomination committee. If any of the three largest shareholders waive their right to appoint a member, the next shareholder in terms of votes, shall be contacted and be given one week to appoint a member. The names of the chair of the board, together with the three appointed members and the names of the parties they have been appointed by shall be made public as soon as the nomination committee has been appointed, which should be no later than six months prior to the annual general meeting. If, at this time, fewer than three owners have expressed a desire to participate in the nomination committee, the nomination committee shall consist of fewer than four members. The quorum for the nomination committee is met when more than half of its members participate. In determining the nomination committee's decision, the opinion receiving more than half of the votes from the attending members shall prevail. In case of a tie, the chair of the nomination committee shall cast the deciding vote in favor of the seconded opinion.

The mandate period of the nomination committee will last until a new nomination committee has been appointed. Unless the members agrees otherwise, the chair of the nomination committee shall be the member appointed by the largest shareholder. However, the first meeting shall be opened by the chair of the board. No remuneration shall be paid to the members of the nomination committee.

If there is material change in the ownership structure and a shareholder subsequently becomes one of the three largest shareholders, they must inform the nomination committee of their wish to participate in the work of the nomination committee. The nomination committee shall then determine whether to offer a seat to that shareholder by either replacing the shareholder with the least votes or adding an additional member to the nomination committee. Changes of ownership less than two months prior to the annual general meeting shall be disregarded. The number of members in the nomination committee may, however, never exceed five. If, for any other reasons, a member leaves the nomination committee or ceases to represent the shareholder who appointed the member, the shareholder that appointed that member shall have the right to appoint a new member. All changes in the composition of the nomination committee shall be published as soon as they occur.

The nomination committee is to prepare and propose for the annual general meeting:

• Election of chair of the annual general meeting
• Election of chair of the board, other board members and number of board members
• Fee to the chair of the board and fees to other board members, as well as compensation for committee work
• Election of auditor and, if applicable, deputy auditor and determination of auditor's fee
• Amendments to this nomination committee instruction for the forthcoming annual general meeting will be made to the extent deemed necessary

The nomination committee shall have the right to incur expenses for the company regarding e.g. recruitment services and other consultancy services that are needed for the nomination committee to conclude its tasks. The nomination committee shall perform the tasks stipulated in the Swedish Corporate Governance Code.

Item 13 - Resolution on approval of remuneration report

The board of directors proposes that the meeting resolves to approve the board of directors' report on remuneration pursuant to Chapter 8, Section 53 a of the Swedish Companies Act.

Item 14 - Resolution on guidelines for remuneration to executive management

The board of directors proposes that the general meeting resolves on the following guidelines for determining remuneration and other compensation to members of the executive management.

Proposed changes to the guidelines

The main proposed change in the board of directors' proposal, compared to the guidelines adopted by the annual general meeting 2024, is a clarification that members of the executive management may request so-called salary exchanging (sw. löneväxling) (i.e. receiving part of their salary in the form of pension contributions instead of cash payments), provided it can be carried out in a cost-neutral manner for the company. Besides this, some minor editorial adjustments are proposed.

Applicability of the guidelines

Board members, the chief executive officer (the "CEO"), the chief financial officer (the "CFO") and members of the group management fall within the provisions of these guidelines. The guidelines are applicable to remuneration agreed, and amendments to remuneration already agreed, after adoption of the guidelines by the annual general meeting 2025. These guidelines do not apply to any remuneration resolved upon by the general meeting, such as fees for the board of directors and share-related incentive programs.

The guidelines' promotion of the company's business strategy, long-term interests and sustainability

The company's business idea is to acquire, develop and manage high-quality properties in Europe with daily good store chains as anchor tenants. The company currently owns approximately 640 properties in Europe. For more information regarding the company's business strategy, please refer to Cibus' latest annual report.

A prerequisite for the successful implementation of the company's business strategy and safeguarding of its long-term interests, including its sustainability, is that the company is able to recruit and retain qualified personnel. To this end, it is necessary that the company offers competitive remuneration. These guidelines enable the company to offer the executive management a competitive total remuneration.

A long-term warrant plan has been implemented. The plan has been resolved upon by the general meeting and is therefore excluded from these guidelines. The long-term warrant plans proposed by the board of directors to the annual general meeting 2025 for approval is excluded for the same reason. The performance criteria used to assess the outcome of the plans are distinctly linked to the business strategy and thereby to the company's long-term value creation, including its sustainability. The plans are further conditional upon the participant's own investment and certain holding periods of several years. For more information regarding these plans, including the criteria which the outcome depends on, please see the company's website, www.cibusnordic.com.

Variable cash remuneration covered by these guidelines shall aim at promoting the company's business strategy and long-term interests, including its sustainability.

Types of remuneration, etc.

The remuneration shall be on market terms and competitive, and may consist of the following components: fixed cash salary, variable cash remuneration, pension benefits and other benefits. Additionally, the general meeting may resolve on, among other things, share-related or share price-related remuneration. The satisfaction of criteria for awarding variable cash remuneration shall be measured over a period of one or several years. The variable cash remuneration may amount to not more than 50 per cent of the total fixed cash salary under the measurement period.

Pension benefits, including health insurance, shall be premium defined unless the individual concerned is subject to defined benefit pension under mandatory collective agreement provisions. The pension premiums for premium defined pension may amount to not more than 30 per cent of the income which is the basis for the pension. Executives shall have the right to request so-called salary exchanging (sw. löneväxling) (i.e. receiving part of their salary in the form of pension contributions instead of cash payments), provided this can be carried out in a cost-neutral manner for the company.

For employments governed by rules other than Swedish, pension benefits and other benefits may be duly adjusted for compliance with mandatory rules or established local practice, considering, to the extent possible, the overall purpose of these guidelines.

Termination of employment

The notice period may not exceed twelve months if notice of termination of employment is made by the company. Fixed cash salary during the period of notice and severance pay may together not exceed an amount equivalent to the fixed cash salary for two years. The period of notice may not to exceed six months without any right to severance pay when termination is made by the executive.

Additionally, remuneration may be paid for non-compete undertakings. Such remuneration shall compensate for loss of income and shall only be paid in so far as the previously employed executive is not entitled to severance pay. The remuneration shall be based on the fixed cash salary at the time of termination of employment and be paid during the time the non-compete undertaking applies, however not for more than six months following termination of employment.

Criteria for awarding variable cash remuneration, etc.

The variable cash remuneration shall be linked to predetermined and measurable criteria which can be financial or non-financial. They may also be individualized, quantitative or qualitative objectives. The criteria shall be designed so as to contribute to the company's business strategy and long-term interests, including its sustainability, by for example being clearly linked to the business strategy or promote the executive's long-term development.

To which extent the criteria for awarding variable cash remuneration has been satisfied shall be assessed and determined when the measurement period has ended. The board of directors is responsible for the evaluation so far as it concerns variable cash remuneration to the CEO. For variable cash remuneration to other executives, the CEO is responsible for the evaluation. For financial objectives, the evaluation shall be based on the latest financial information made public by the company.

Salary and employment conditions for employees

In the preparation of the board of directors' proposal for these remuneration guidelines, salary and employment conditions for employees of the company have been considered by including information on the employees' total income, the components of the remuneration and increase and growth rate over time, in the board of directors' basis of decision when evaluating whether the guidelines and the limitations set out herein are reasonable.

The decision-making process to determine, review and implement the guidelines

The board of directors shall prepare a proposal for new guidelines when there is need for significant changes and at least every fourth year and submit it to the general meeting. The guidelines shall be in force until new guidelines are adopted by the general meeting. The board of directors shall also monitor and evaluate programs for variable remuneration for the executive management, the application of the guidelines for executive remuneration as well as the current remuneration structures and compensation levels in the company. The CEO and other members of the executive management do not participate in the board of directors' processing of and resolutions regarding remuneration-related matters in so far as they are affected by such matters.

Derogation from the guidelines

The board of directors may temporarily resolve to derogate from the guidelines, in whole or in part, if in a specific case there is special cause for the derogation and a derogation is necessary to serve the company's long-term interests, including its sustainability, or to ensure the company's financial viability.

Item 15 - Resolution on amendment of the articles of association

The board of directors proposes that the meeting resolves on an amendment of the company's articles of association, mainly in accordance with the following.

Current wording:

§ 4 Share capital
The share capital shall be not less than EUR 250,000 and not more than EUR 1,000,000.

§ 5 Shares
The number of shares shall be not less than 25,000,000 and not more than 100,000,000.

Proposed new wording:

§ 4 Share capital
The share capital shall be not less than EUR 750,000 and not more than EUR 3,000,000.

§ 5 Shares
The number of shares shall be not less than 75,000,000 and not more than 300,000,000.

In addition to the above, amendments of an editorial nature are proposed.

The board of directors, or a party designated by the board, has the right to decide on minor changes to the general meeting's resolution that may be necessary in connection with registration of the resolution with the Swedish Companies Registration Office or due to other formal requirements.

Item 16 - Resolution on authorization for the board of directors to resolve upon new issue of shares, warrants and/or convertibles

The board of directors proposes that the meeting resolves to authorize the board of directors to, on one or several occasions, during the period until the next annual general meeting, resolve on issue of shares, warrants and/or convertible bonds, with or without deviation from the shareholders' preferential rights. Furthermore, the proposal provides that the issue may be made against payment in cash, by set-off or in kind, or subject to other conditions.

1. If the board of directors resolves on an issue of shares, warrants and/or convertible bonds with preferential rights for the shareholders, the total number of shares that may be issued, or accrued through the exercise of warrants or the conversion of convertible bonds, under the authorization under this item may not exceed 20 percent of the total number of outstanding shares in the company at the time of the annual general meeting.
2. If the board of directors resolves to issue shares, warrants and/or convertible bonds without preferential rights for the shareholders, the total number of shares that may be issued, or accrued through the exercise of warrants or the conversion of convertible bonds, may not exceed an additional 20 percent of the total number of outstanding shares in the company at the time of the annual general meeting, and 2) the total number of shares that may be allotted, or be accrued through the exercise of warrants or conversion of convertible bonds, to an individual natural or legal person may not exceed 8 percent of the total number of shares in the company at the time of the annual general meeting.

The purpose of the authorization, and the reason for any deviation from the shareholders' preferential rights, is to be able to continuously adjust the company's capital structure and thereby contribute to increased shareholder value and to enable the company to finance, wholly or partly, any future acquisitions by issuing shares, warrants and/or convertible bonds as payment in connection with agreements on acquisitions or to raise capital for such acquisitions.

The board of directors, or a party designated by the board of directors, has the right to decide on minor changes to the general meeting's resolution that may be necessary in connection with registration of the resolution with the Swedish Companies Registration Office or due to other formal requirements.

Item 17 - Resolution on authorization for the board of directors to resolve on acquisition and transfer of own shares

The board of directors proposes that the meeting resolves upon that the board of directors shall be authorized to, on one or several occasions for the period until the next annual general meeting, acquire own shares in the company so that, as a maximum, the company's holding following the acquisition does not exceed ten percent of all the shares in the company at any time. Acquisitions may only be conducted at Nasdaq Stockholm and at a price that is within the registered range for the share price prevailing at any time, that is, the range between the highest bid price and the lowest ask price. However, for acquisitions carried out by a stock broker on behalf of the company, the price for the shares may correspond to the volume weighted average price during the time period within which the shares were acquired, even if the volume weighted average price on the day of delivery to Cibus falls outside the price range. Payment for the shares shall be made in cash.

The board of directors further proposes that the general meeting resolves to authorize the board of directors to, on one or several occasions for the period until the next annual general meeting, resolve upon transfer of own shares. The number of shares to be transferred may not exceed the total number of shares held by the company at any time. Transfers may be conducted on or outside Nasdaq Stockholm, including a right to resolve upon deviations from the shareholders' preferential rights. Transfer of shares on Nasdaq Stockholm shall take place at a price within the price range applicable at any given time. Transfers of shares outside Nasdaq Stockholm shall be conducted at a price in cash or value in property that corresponds to, at the time of the transfer, the current market share price of the shares in the company that are transferred, with such deviation that the board of directors considers appropriate depending on the circumstances of each case.

The purpose of the authorizations is to provide the board of directors with greater opportunities to adapt the company's capital structure and thereby contribute to increased shareholder value and to enable the company to, wholly or partly, finance any future acquisitions in a cost-effective manner through payment with the company's own shares.

Item 18 - Resolution on warrant plan, issue of warrants of series 2025/2028 and transfer of warrants of series 2025/2028

The board of directors proposes that the meeting resolves upon introducing a warrant plan (the "Warrant Plan") for employees in the group. The objective of the Warrant Plan, and the reason for deviating from the shareholders' preferential rights, is to strengthen the link between employees and created shareholder value. By that means, it is considered that there will be an increased alignment of interests between employees and shareholders in the company. The intention is for the Warrant Plan to be annually recurring and resolved on at future annual general meetings based on proposals from the board.

1. Issue of warrants and participants
   
   1.1 The company shall issue up to 390,000 warrants of series 2025/2028 under the Warrant Plan. The right to subscribe for the warrants shall, with deviation from the shareholders' preferential rights, be granted to a wholly owned subsidiary of the company (the "Subsidiary"), with the right and obligation as set forth in section 2 below to transfer the warrants to employees in the group in accordance with the distribution presented in section 1.3 below. Over-subscription may not take place. The warrants shall be issued without consideration to the Subsidiary.
   
   1.2 Subscription of the warrants of series 2025/2028 shall take place within four weeks from the date of the resolution to issue warrants. The board of directors shall have the right to extend the subscription period.
   
   1.3 The right to acquire warrants of series 2025/2028 shall be granted to the employees of the group in accordance with the following categories:

   Category	Guaranteed number of warrants per person
   A. CEO	75,000
   B. CFO and COO	56,250 Total within the category: 112,500
   C. CIO Denmark & Norway, CIO Finland, CIO Sweden, Treasury Manager	30,000 Total within the category: 120,000
   D. Other employees (group 1) (approximately 5 persons)	15,000 Total within the category: 75,000
   E. Other employees (group 2) (approximately 1 person)	7,500

   
   1.4 Should warrants of series 2025/2028 remain after all applications have been satisfied up to the guaranteed level as set out in the table in section 1.3 above, the remaining warrants shall be available for allotment to participants regardless of category. Such additional allotment of warrants shall however amount to a maximum of 50 percent in relation to the guaranteed level which is set out in the table above. Should the remaining number of warrants not be sufficient to satisfy all applications, the remaining warrants shall be allotted pro rata in relation to the number of warrants acquired by each participant. The company's board of directors shall decide on the final allotment.
   
   1.5 The right to acquire warrants from the Subsidiary shall only apply to the employees in the group who have not terminated their employment, been dismissed or whose employment has otherwise ceased at the end of the application period. Warrants may also be offered to future new employees. For such acquisitions, the conditions shall be the same or equivalent to what is stated in this resolution. This means, among other things, that acquisitions shall be made at the applicable market value. The fact that warrants may be offered to future new employees can mean that the vesting period in some cases could be less than three years. However, the company considers this to not affect the suitability of the Warrant Program as the purposes that justify the implementation of the Warrant Program are not affected by the time of year at which the participant agrees to participate in the Warrant Program.
   
   
2. Transfer of warrants and subsidy
   
   2.1 The Subsidiary shall transfer the warrants of series 2025/2028 to the participants at market value. The market value of the warrants of series 2025/2028 is not more than approximately SEK 9.0 per warrant, according to a preliminary valuation. The preliminary valuation is based on a market value of the underlying share of SEK 157.2 which corresponded to the closing price of the company's share on 4 March 2025, an assumed subscription price of SEK 176.5 per share and takes into account the value limitation set out in section 3.2 below. The Black & Scholes pricing model has been used for the valuation under the assumption of a risk-free interest rate of 2.0 percent, that future dividends are in line with analysts' estimates, and a volatility of 26 percent. The preliminary valuation has been performed by Svalner Skatt & Transaktion KB.
   
   2.2 The company intends to subsidize the warrant premium for the warrants by the company repaying the amount paid by the participant as payment for the warrants by means of a cash bonus. The company will pay such social security contributions (Sw. sociala avgifter) as the company is legally obliged to pay as a result of payment of the cash bonus. Only premiums for warrants that do not exceed the guaranteed level for each participant will be subsidized, in accordance with what is stated in item 1.3 above.
   
   2.3 The transfer of warrants to employees outside Sweden is subject to (i) tax implications, (ii) the absence of legal obstacles, and (iii) the board's assessment that such a transfer can be carried out with reasonable administrative and financial resources. See also further conditions under section 5.1.
   
   
3. Time and price for subscription for shares
   
   3.1 Each warrant shall entitle to subscription of one (1) share in the company at a subscription price in SEK of 110 percent of the average volume-weighted price paid for the company's share on Nasdaq Stockholm during the period from and including 24 April 2025 up until and including 2 May 2025.[1] If the company has inside information during the aforementioned period, the board of directors shall be entitled to postpone the measurement period. The subscription price may not be lower than the current quota value of the share.
   
   3.2 If the average price of the company's share, calculated as set out in the complete terms and conditions for the warrants, in connection with subscription of new shares by exercise of the warrants, exceeds a value of not less than 160 percent and not more than 180 percent (the "Cap") of the calculated volume-weighted average price paid for the company's share on Nasdaq Stockholm during the period from and including 24 April 2025 up until and including 2 May 2025, a recalculated lower number of shares to which each warrant entitles shall apply. The board of directors is assigned to decide on the level of the Cap in connection with the launch of the Warrant Plan.
   
   3.3 Subscription for shares in accordance with the terms and conditions for the warrants of series 2025/2028 (see the separate terms and conditions that are available at the company's website) may take place during the following time periods:
   
   (i) a period of two weeks from the day following the publication of the company's interim report for the period 1 January - 31 March 2028, but not earlier than 13 April 2028 and no later than 5 June 2028,
   
   (ii) a period of two weeks from the day following the publication of the company's interim report for the period 1 January - 30 June 2028, but not earlier than 16 August 2028 and no later than 6 September 2028, and
   
   (iii) a period of two weeks from the day following the publication of the company's interim report for the period 1 January - 30 September 2028, but not earlier than 12 October 2028 and no later than 30 November 2028.
   
   3.4 If the Cap is reached during any relevant measurement period, the company shall give notice thereof, whereby holders of warrants, in addition to what is stated in section 3.3 above regarding the time for notice of subscription, shall be entitled to subscribe for shares by exercising the subscription right within a two-week period after the date of such notice. "Relevant measurement period" means a period of five trading days after the date of publication of the company's interim reports (including year-end report) during the term of the Warrant Plan.
   
   3.5 However, subscription of shares may not take place during such period when trading with the shares in the company is prohibited pursuant to Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the Market Abuse Regulation), or any corresponding legislation applicable at the relevant point in time.
   
   3.6 The number of shares that the warrants of series 2025/2028 entitle to, and the subscription price may be recalculated on the basis of, among other things, bonus issues, share splits or reverse share splits, rights issues or certain reductions of the share capital or similar actions (whereby also the value limitation in section 3.2 above may be adjusted accordingly). Recalculation of the subscription price may also take place if dividends paid during the term of the Warrant Plan deviate from the dividends forecasted at time of transfer of the warrants that have been used in determining the warrant premium. Complete terms and conditions for the warrants are available at the company's website. The new shares that may be issued if the warrants are exercised are not subject to any restrictions.
   
   3.7 The shares that are newly issued following subscription shall entitle to dividends for the first time on the first record date for dividends which occurs after subscription for shares as a result of exercising the warrants is effected.
   
   3.8 The board of directors of the company may by means of a board resolution and with the consent from the board of directors in the Subsidiary cancel warrants held by the Subsidiary which are not transferred in accordance with section 2. Cancellation shall be registered with the Swedish Companies Registration Office.
   
   
4. Increase of share capital, dilution and costs etc.
   
   4.1 Increase of share capital and dilution
   Upon full subscription and full exercise of the proposed warrants of series 2025/2028, 390,000 new shares may be issued, corresponding to an increase of the company's share capital by EUR 3,900. Such increase corresponds to a dilution of the shareholders' holdings of approximately 0.51 percent of the total number of shares in the company if all warrants of series 2025/2028 are exercised, subject to any recalculation according to the terms and conditions for the warrants. The portion of the subscription price that exceeds the quota value of the shares shall be allocated to the unrestricted share premium reserve.
   
   4.2 Alternative exercise model
   The participants in the Warrant Plan shall have the right to, upon subscription of shares by exercise of the warrants, request that an alternative exercise model shall be applied in accordance with the complete terms and conditions. Upon application of the alternative exercise model, the subscription price for each share shall correspond to the at any time applicable quota value and the warrants shall entitle to a recalculated, generally lower, number of shares.[2] However, the warrants shall not entitle to more than one (1) share per warrant, subject to any recalculation in accordance with the complete terms and conditions for the warrants.
   
   Recalculation of the number of shares that each warrant entitles to subscription of shall be carried out by the company in accordance with the following formula:

   recalculated number of shares that each warrant entitles to subscription of	=	The share's average price during a period of 5 trading days following the first day in the subscription period under which the warrants can be exercised for subscription ("Actual Share Price") reduced by the subscription price
   		Actual Share Price reduced by the quota value of the share

   
   4.3 Costs etc.
   The Warrant Plan is expected to have a marginal impact on the company's financial ratios. The company intends to subsidise the price for the warrants by the company repaying the amount paid by the participant as payment for the warrants by means of a cash bonus. The company will pay such social security contributions (Sw. sociala avgifter) as the company is legally obliged to pay as a result of payment of the bonus amount. The participants will in turn pay income tax on the bonus amount. The subsidy will entail that the company's profit is charged with personnel costs and employer contributions, which are estimated to amount to approximately MSEK 4.5. The company will receive an amount estimated to amount to approximately MSEK 3.5 corresponding to the total warrant premiums, which is reported under equity. The Warrant Plan is otherwise expected to entail only certain limited costs for the company in the form of fees to external advisors and administration of the Warrant Plan. No measures for hedging the Warrant Plan are intended to be taken.
   
   
5. Right of first refusal and lock-up undertakings
   
   5.1 The allotment of warrants of series 2025/2028 is conditional upon the participants, at the time of allotment, having entered into an agreement with the company that grants the company pre-emptive rights and the right to repurchase the warrants under certain conditions.
   
   5.2 Participation in the Warrant Plan requires that the participant has entered into a so-called lock-up undertaking in favour of the company in respect of any shares that the participant may subscribe for in connection with early subscription of shares pursuant to section 3.4 above, meaning that the participant, with customary exceptions, has undertaken not to dispose of these shares until at the earliest in connection with the commencement of the first subscription period pursuant to section 3.3 above.
   
   
6. Preparation of the proposal etc.
   
   6.1 The Warrant Plan has been prepared by the board of directors of the company and has been discussed at board meetings during the spring 2025.
   
   6.2 Apart from the proposed Warrant Plan, the company has three outstanding warrant plans which were introduced in 2021, 2023 and 2024, respectively, for the company's management team. The warrant plan introduced in 2021 was not addressed to the CEO (for a more detailed description of outstanding warrant plans, see the company's renumeration report for the financial year 2024). Aside from this, there are no outstanding share-based incentive plans in the company.
   
   
7. Special authorization for the board of directors
   
   7.1 The board of directors is authorized to make such minor adjustments to the resolution by the meeting that may be required for registration with the Swedish Companies Registration Office and Euroclear Sweden AB or due to other formal requirements. The board of directors shall also have the right to make such minor adjustments to the Warrant Plan as required by applicable foreign laws and regulations.

Item 19 - Resolution on Belgian warrant plan and issue of warrants of series 2025/2029

The board of directors proposes that the meeting resolves upon introducing a warrant plan (the "Belgian Warrant Plan") for employees and management contractors in Belgium. The objective of the Belgian Warrant Plan, and the reason for deviating from the shareholders' preferential rights, is to strengthen the link between employees and management contractors and created shareholder value. By that means, it is considered that there will be an increased alignment of interests between employees and management contractors and shareholders in the company. The intention is for the Belgian Warrant Plan to be annually recurring and resolved on at future annual general meetings based on proposals from the board.

1. Issue of warrants and participants
   
   1.1 The company shall issue up to 157,500 warrants of series 2025/2029 under the Belgian Warrant Plan. The right to subscribe for the warrants shall, with deviation from the shareholders' preferential rights, be granted to the participants in accordance with the distribution presented in section 1.3 below. Over-subscription may not take place. The warrants shall be issued free of charge to the participants.
   
   1.2 Subscription of the warrants of series 2025/2029 shall take place within four weeks from the date of the resolution to issue warrants. The board of directors shall have right to extend the subscription period.
   
   1.3 The right to subscribe for warrants of series 2025/2029 shall be granted to the employees and management contractors in Belgium in accordance with the following categories:

   Category	Guaranteed number of warrants per person
   A. CFO Benelux, COO Benelux	30,000 Total within the category: 60,000
   B. Other employees (group 1) (approximately 4 persons)	15,000 Total within the category: 60,000
   C. Other employees (group 2) (approximately 5 persons)	7,500 Total within the category: 37,500

   
   1.4 Should warrants of series 2025/2029 remain after all applications have been satisfied up to the guaranteed level as set out in the table in section 1.3 above, the remaining warrants shall be available for allotment to participants regardless of category. Such additional allotment of warrants shall however amount to a maximum of 50 percent in relation to the guaranteed level which is set out in the table above. Should the remaining number of warrants not be sufficient to satisfy all applications, the remaining warrants shall be allotted pro rata in relation to the number of warrants subscribed for by each participant. The company's board of directors shall decide on the final allotment and the total amount of warrants that will be offered to each participant.
   
   1.5 The right to subscribe for warrants shall only apply to the employees and management contractors in Belgium who have not terminated their employment or consultancy agreement, been dismissed or whose employment or consultancy agreement has otherwise ceased at the end of the application period. Warrants may also be offered to future new employees and management contractors. For such acquisitions, the conditions shall be the same or equivalent to what is stated in this resolution.
   
   1.6 The grant of warrants to employees or management contractors outside Sweden is subject to (i) tax implications, (ii) the absence of legal obstacles, and (iii) the board's assessment that such a transfer can be carried out with reasonable administrative and financial resources.
2. Transfer of warrants
   
   2.1 The warrants of series 2025/2029 under the Belgian Warrant Plan will be non-transferable by the participants of the Belgian Warrant Plan, except if the participant is a personal service company, in which case the warrants may be transferred by that personal service company to the individual who provides services to that personal service company.
   
   
3. Time and price for subscription for shares
   
   3.1 Each warrant shall entitle to subscription of one (1) share in the company at a subscription price corresponding to the lowest of (i) the average closing price of the company share during the thirty days preceding the offer date and (ii) the last closing price of the company share on the day preceding the offer date, which will occur during the four week subscription period as set out in section 1.2. The subscription price may not be lower than the current quota value of the share.
   
   3.2 Subscription for shares in accordance with the terms and conditions for the warrants of series 2025/2029 (see the separate terms and conditions that are available at the company's website) may take place during a period of two weeks from the day following the publication of the company's interim report for the period 1 January - 31 December 2028, but not earlier than 17 February 2029 and not later than 23 March 2029.
   
   3.3 However, subscription of shares may not take place during such period when trading with the shares in the company is prohibited pursuant to Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the Market Abuse Regulation), or any corresponding legislation applicable at the relevant point in time.
   
   3.4 The terms and conditions of the warrants of series 2025/2029 may be adjusted in case the company is involved in any actions that may have an effect on the market value of the shares in the company (such as, among other things, bonus issues, share splits or reverse share splits, rights issues or certain reductions of the share capital or similar actions) so as to ensure the economic neutrality of these actions and to avoid that the employee/management contractors would economically be disadvantaged by these actions. Complete terms and conditions for the warrants are available at the company's website. The new shares that may be issued if the warrants are exercised are not subject to any restrictions.
   
   3.5 The shares that are newly issued following subscription shall entitle to dividends for the first time on the first record date for dividends which occurs after subscription for shares as a result of exercising the warrants is effected.
   
   
4. Increase of share capital, dilution and costs etc.
   
   4.1 Increase of share capital and dilution
   Upon full subscription and full exercise of the proposed warrants of series 2025/2029, 157,500 new shares may be issued, corresponding to an increase of the company's share capital by EUR 1,575. Such increase corresponds to a dilution of the shareholders' holdings of approximately 0.21 percent of the total number of shares in the company if all warrants of series 2025/2029 are exercised, subject to any recalculation according to the terms and conditions for the warrants. The portion of the subscription price that exceeds the quota value of the shares shall be apportioned to the unrestricted share premium reserve.
   
   4.2 Costs etc.
   The Belgian Warrant Plan is expected to have a marginal impact on the company's financial ratios. The costs for the Belgian Warrant Plan will be reported as personnel costs in the income statement and are expected to amount to approximately MSEK 1.9 and are, besides this, expected to entail only certain limited costs for the company in the form of fees to external advisors and administration of the Belgian Warrant Plan. No measures for hedging the Belgian Warrant Plan are intended to be taken.
   
   
5. Leaver event
   
   5.1 The warrants of series 2025/2029 under the Belgian Warrant Plan shall lapse and become null and void when the participant's employment in the company or service relationship with the company is terminated, by the notice of termination of employment or assignment or termination by death, during the term of the Belgian Warrant Plan, without any compensation being due to that participant.
6. Preparation of the proposal etc.
   
   6.1 The Belgian Warrant Plan has been prepared by the board of directors of the company and has been discussed at board meetings during the spring 2025.
   
   6.2 Apart from the proposed Belgian Warrant Plan, the company has three outstanding warrant plans which were introduced in 2021, 2023 and 2024, respectively, for the company's management team. The warrant plan introduced in 2021, was not addressed to the CEO (for a more detailed description of outstanding warrant plans, see the company's renumeration report for the financial year 2024). Aside from this, there are currently no outstanding share-based incentive plans in the company.
   
   
7. Special authorization for the board of directors
   
   7.1 The board of directors is authorized to make such minor adjustments to the resolution by the meeting that may be required for registration with the Swedish Companies Registration Office and Euroclear Sweden AB or due to other formal requirements. The board of directors shall also have the right to make such minor adjustments to the Belgian Warrant Plan as required by applicable foreign laws and regulations.

MAJORITY REQUIREMENTS

Resolutions under item 15, 16 and 17 will not be valid unless supported by shareholders representing at least two thirds of both the votes cast and the shares represented at the meeting. Resolutions under items 18 and 19 will not be valid unless supported by shareholders representing at least nine tenths of both the votes cast and the shares represented at the meeting.

DOCUMENTS

The complete documents in accordance with the Swedish Companies Act will be available at the company and on the company's website as from no later than Thursday 20 March 2025 and will be sent immediately without charge to any shareholders who so request and has states their address. The documents will also be available at the meeting.

NUMBER OF SHARES AND VOTES

As of the date of this notice, the total amount of shares and votes in the company amounts to 76,285,045. The company holds no treasury shares as of the date of this notice.

INFORMATION AT THE MEETING

The shareholders are reminded of their right to request information from the board of directors and the CEO according to Chapter 7, Sections 32 and 57 of the Swedish Companies Act.

PROCESSING OF PERSONAL DATA

For information on how your personal data is processed, please see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf 

____________

Stockholm in March 2025

Cibus Nordic Real Estate AB (publ)

The board of directors

For further information, please contact

Christian Fredrixon, CEO
christian.fredrixon@cibusnordic.com
+46 (0)8 12 439 100

Pia-Lena Olofsson, CFO
pia-lena.olofsson@cibusnordic.com
+46 (0)8 12 439 100

About Cibus Nordic Real Estate

Cibus is a real estate company listed on Nasdaq Stockholm Mid Cap. The company's business idea is to acquire, develop and manage high-quality properties in Europe with grocery retail chains as anchor tenants. The company currently owns more than 640 properties in Europe. The largest tenants are Kesko, Tokmanni, Coop Sweden, S Group, Rema 1000, Dagrofa, Carrefour and Lidl.

[1] The subscription price may be recalculated to euro based on the official SEK/EUR rate of the Swedish Central Bank.

[2] The subscription price may be recalculated to euro based on the official SEK/EUR rate of the Swedish Central Bank.